Market Research Industry Reports

DBK Pharmaceutical - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

DBK Pharmaceutical (DBK Pharma) is a pharmaceutical company that develops, manufactures and markets pharmaceutical, herbal brands, food supplements, cosmetics and veterinary products. The companys pharmaceutical products include chitocal capsule, debeskon, rentensar tablets, pressothioval, lidocaine with adrenaline, malsa cream, depahair, lycomen, debosteobone tablets, dermaflutisone cream, bold stop, and others. Its cosmetics products comprise skincare and personal care products. DBK Pharma offers veterinary products such as gentamycin, gamamox, ronoxy, solpharon, debatoltra, enterobiotic, dectomectin, painclear and dimetro. The company retails products through a network of distributors in Middle East and African countries. DBK Pharma is headquartered in Cairo, Egypt.

DBK Pharmaceutical - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




DBK Pharmaceutical, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DBK Pharmaceutical, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DBK Pharmaceutical, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DBK Pharmaceutical, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DBK Pharmaceutical, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
DBK Pharmaceutical, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Marei Bin Mahfouz Acquires 25% Stake in DBK Pharma for USD2.2 Million 10
Equity Offering 11
DBK Pharma to Raise USD15.8 Million in Private Placement of Shares 11
DBK Pharma Postpones Initial Public Offering 12
DBK Pharmaceutical - Key Competitors 13
DBK Pharmaceutical - Key Employees 14
DBK Pharmaceutical - Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List Of Tables

List of Tables
DBK Pharmaceutical, Pharmaceuticals & Healthcare, Key Facts 2
DBK Pharmaceutical, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DBK Pharmaceutical, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DBK Pharmaceutical, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DBK Pharmaceutical, Deals By Therapy Area, 2012 to YTD 2018 8
DBK Pharmaceutical, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Marei Bin Mahfouz Acquires 25% Stake in DBK Pharma for USD2.2 Million 10
DBK Pharma to Raise USD15.8 Million in Private Placement of Shares 11
DBK Pharma Postpones Initial Public Offering 12
DBK Pharmaceutical, Key Competitors 13
DBK Pharmaceutical, Key Employees 14

List Of Figures

List of Figures
Debiopharm International SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Debiopharm International SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Debiopharm International SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Debiopharm International SA, Medical Devices Deals, 2012 to YTD 2018 9

Deutsche Bank Wealth Management (DBK) : Company Profile and SWOT Analysis

SynopsisTimetrics Deutsche Bank Wealth Management (DBK) : Company Profile and SWOT Analysis contains in depth information and data about the company and its operations. The profile contains a company overview,

USD 125View Report

DBK Pharmaceutical - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DBK Pharmaceutical (DBK Pharma) is a pharmaceutical company that develops, manufactures and markets pharmaceutical, herbal brands, food supplements, cosmetics and veterinary products. The companys pharmaceutical products include chitocal capsule, debeskon,

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :16
Country :Egypt
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube